PEG-exenatide (ProLynx)

N/A

Report date: 2025/03/20 15:27:09

Base Information

Drug NamePEG-exenatide (ProLynx)
Drug Alias NamePEG-exenatide prodrug (ProLynx)PEG-linker-exenatide (ProLynx)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProlynx Llc
China Registration ClassN/A

Develop Information

Active CompaniesProlynx Llc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A